Skip to main content
Log in

Protective Mechanism of MIF Inhibitor ISO-1 on Intrahepatic Bile Duct Cells in Rats with Severe Acute Pancreatitis

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Aims

This study aimed to explore the protection mechanism of ISO-1 on severe acute pancreatitis-associated intrahepatic bile duct (IBD) injury in rats.

Methods

Forty-eight specific-pathogen-free male Wistar rats were randomly divided into four groups (N = 12): a sham operation group (SO group), a severe acute pancreatitis model group (SAP group), a ISO-1 treatment group (ISO-1 + SAP group), and a ISO-1 control group (ISO-1 + SO group). All rats were killed after 12 h of being made models. Immunohistochemistry was used to detect the expression of MIF and P38 in IBD cells. MIF mRNA expression in IBD cells was observed using real-time fluorescent quantitative polymerase chain reaction (real-time PCR). In addition, Western blotting was performed to detect the protein expression of P38, phosphorylated P38 (P-P38), nuclear factor-κB (NF-κB p65), and tumor necrosis factor alpha (TNF-α). Enzyme-linked immunosorbent assays were used to analyze the levels of TNF-α, IL-1β, and IL-6 in the IBD of rats.

Results

Compared with SAP, after treatment with ISO-1, the pathological injuries of pancreas, liver, and IBD cells in ISO-1 treatment group remarkably relieved. The expression of MIF in the IBD cells was significantly downregulated both at mRNA and at protein levels in ISO-1 treatment group. Besides, the protein expression levels of P38, P-P38, NF-κBp65, TNF-α, IL-1β, and IL-6 in the IBD in rats were also significantly decreased in ISO-1 treatment group (all P < 0.05).

Conclusion

ISO-1 may protect the IBD cells, reduce pathological injuries, and reduce the inflammatory response in SAP rats. Its mechanisms may be via inhibiting the expression of MIF and then blocking the activation of p38-MAPK and NF-κB signaling pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

Abbreviations

MIF:

Macrophage migration inhibitory factor

ISO-1:

A specific small molecule inhibitor of MIF

SAP:

Severe acute pancreatitis

AP:

Acute pancreatitis

IBD:

Intrahepatic bile duct

SPF:

Specific-pathogen-free

SO:

Sham operation

NF-κB:

Nuclear factor-κB

TNF:

Tumor necrosis factor

ELISA:

Enzyme-linked immunosorbent assays

IL:

Interleukin

MODS:

Multiple organ dysfunction syndrome

MOF:

Multiple organ failure

SIRS:

Systemic inflammatory response syndrome

ARDS:

Acute respiratory distress syndrome

AP:

Acute pancreatitis

MAPK:

Mitogen-activated protein kinase

ICAM:

Intercellular adhesion molecule

VCAM:

Vascular cell adhesion protein

MCP:

Monocyte chemoattractant protein

HRP:

Horseradish peroxidase

H&E:

Hematoxylin and eosin

PBS:

Phosphate-buffered saline

IOD:

Integral optical density

SEM:

Standard error of the mean

References

  1. Wang B, Zhao KL, Hu WJ, Zuo T, Ding YM, Wang WX. Macrophage migration inhibitor promoted the intrahepatic bile duct injury in rats with severe acute pancreatitis. Dig Dis Sci. 2019;64:759–772. https://doi.org/10.1007/s10620-018-5379-7.

    Article  CAS  PubMed  Google Scholar 

  2. Aeberli D, Yang Y, Mansell A, et al. Endogenous macrophage migration inhibitory factor modulates glucocorticoid sensitivity in macrophages via effects on MAP kinase phosphatase-1 and p38 MAP kinase. FEBS Lett. 2006;580:974–981.

    Article  CAS  Google Scholar 

  3. Chuang CC, Chuang YC, Chang WT, et al. Macrophage migration inhibitory factor regulates interleukin-6 production by facilitating nuclear factor-κB activation during Vibrio vulnificus infection. BMC Immunol. 2010;11:50.

    Article  Google Scholar 

  4. Takahashi K, Koga K, Linge HM, et al. Macrophage CD74 contributes to MIF-induced pulmonary inflammation. Respir Res. 2009;10:33.

    Article  Google Scholar 

  5. Paszt A, Eder K, Szabolcs A, et al. Effects of glucocorticoid agonist and antagonist on the pathogenesis of l-arginine-induced acute pancreatitis in rat. Pancreas. 2008;36:369–376.

    Article  CAS  Google Scholar 

  6. Schmidt J, Rattner DW, Lewandrowski K, et al. A better model of acute pancreatitis for evaluating therapy. Ann Surg. 1992;215:44–56.

    Article  CAS  Google Scholar 

  7. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, et al. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Transplantation. 1993,5:265–1272.

  8. Lubetsky JB, Dios A, Han J, et al. The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents. J Biol Chem. 2002;277:24976–24982.

    Article  CAS  Google Scholar 

  9. Sakai Y, Masamune A, Satoh A, et al. Macrophage migration inhibitory factor is a critical mediator of severe acute pancreatitis. Gastroenterology. 2003;124:725–736.

    Article  CAS  Google Scholar 

  10. Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol. 2003;3:791–800.

    Article  CAS  Google Scholar 

  11. Mazzon E, Impellizzeri D, Di Paola R, et al. Effects of mitogen-activated protein kinase signaling pathway inhibition on the development of cerulein-induced acute pancreatitis in mice. Pancreas. 2012;41:560–570.

    Article  CAS  Google Scholar 

  12. Nattee P, Honsawek S, Chongsrisawat V, et al. Elevated serum macrophage migration inhibitory factor levels in post-operative biliary atresia. Asian J Surg. 2009;32:109–113.

    Article  Google Scholar 

  13. Nakajima H, Takagi H, Horiguchi N, et al. Lack of macrophage migration inhibitory factor protects mice against concanavalin A-induced liver injury. Liver Int. 2006;26:346–351.

    Article  CAS  Google Scholar 

  14. Chuang CC, Wang ST, Chen WC, et al. Increases in serum macrophage migration inhibitory factor in patients with severe sepsis predict early mortality. Shock. 2007;27:503–506.

    Article  CAS  Google Scholar 

  15. Murr MM, Yang J, Fier A, et al. Regulation of Kupffer cell TNF gene expression during experimental acute pancreatitis: the role of p38-MAPK, ERK1/2, SAPK/JNK, and NF-κB. J Gastrointest Surg. 2003;7:20–25.

    Article  Google Scholar 

  16. Murr MM, Yang J, Fier A, et al. Pancreatic elastase induces liver injury by activating cytokine production within Kupffer cells via nuclear factor-κB. J Gastrointest Surg. 2002;6:474–480.

    Article  Google Scholar 

  17. Hietaranta A, Mustonen H, Puolakkainen P, et al. Proinflammatory effects of pancreatic elastase are mediated through TLR4 and NF-κB. Biochem Biophys Res Commun. 2004;323:192–196.

    Article  CAS  Google Scholar 

  18. Cuzzocrea S, Mazzon E, Di Paola R, et al. Glycogen synthase kinase-3 beta inhibition attenuates the degree of arthritis caused by type II collagen in the mouse. Clin Immunol. 2006;120:57–67.

    Article  CAS  Google Scholar 

  19. Yu J, Deng WH, Wang WX, et al. Inhibition of poly(ADP-ribose) polymerase attenuates acute kidney injury in sodium taurocholate-induced acute pancreatitis in rats. Pancreas. 2012;41:1299–1305.

    Article  CAS  Google Scholar 

  20. Deng H, Zhang N, Wang Y, et al. S632A3, a new glutarimide antibiotic, suppresses lipopolysaccharide-induced pro-inflammatory responses via inhibiting the activation of glycogen synthase kinase 3 beta. Exp Cell Res. 2012;318:2592–2603.

    Article  CAS  Google Scholar 

  21. Deng WH, YuJ, Wang WX, et al. Zerumbone attenuates the severity of acute necrotizing pancreatitis and pancreatitis-induced hepatic injury. Mediators Inflamm, 2012, 2012: 156507.

  22. Schafer C, Tietz AB, Goke B. Pathophysiology of acute experimental pancreatitis: lessons from genetically engineered animal models and new molecular approaches. Digestion. 2005;71:162–172.

    Article  Google Scholar 

  23. Granger J, Remick D. Acute pancreatitis: models, markers, and mediators. Shock. 2005;24:45–51.

    Article  CAS  Google Scholar 

  24. Pastor CM, Frossard JL. Are genetically modified mice useful for the understanding of acute pancreatitis. FASEB J. 2001;15:893–897.

    Article  CAS  Google Scholar 

  25. Gulcubuk A, Altunatmaz K, Sonmez K, et al. Effects of curcumin on tumour necrosis factor-alpha and interleukin-6 in the late phase of experimental acute pancreatitis. J Vet Med A Physiol Pathol Clin Med. 2006;53:49–54.

    Article  CAS  Google Scholar 

  26. Abcouwer S F, Norman J, Fink G, et al. Tissue-specific regulation of glutamine synthetase gene expression in acute pancreatitis is confirmed by using interleukin-1 receptor knockout mice. Surgery, 1996, 120: 255–263, 263–264.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bin Wang.

Ethics declarations

Conflict of interest

This study has no conflict of interest with any organization or individual.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, B., Zhao, K., Hu, W. et al. Protective Mechanism of MIF Inhibitor ISO-1 on Intrahepatic Bile Duct Cells in Rats with Severe Acute Pancreatitis. Dig Dis Sci 66, 3415–3426 (2021). https://doi.org/10.1007/s10620-020-06674-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-020-06674-9

Keywords

Navigation